Osteosarcopenia in Finland: prevalence and associated factors.
Epidemiology
Older adults
Osteoporosis
Osteosarcopenia
Prevalence
Sarcopenia
Journal
Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988
Informations de publication
Date de publication:
30 Aug 2024
30 Aug 2024
Historique:
received:
31
01
2024
accepted:
12
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
30
8
2024
Statut:
epublish
Résumé
This cross-sectional study investigated osteosarcopenia prevalence and its correlates among 2142 adults aged 55 and older in Finland. Findings show 3.9% had osteosarcopenia, while 13.8% and 11.1% had probable sarcopenia only or osteoporosis only, respectively. Osteosarcopenia was associated with low BMI, impaired mobility, ADL limitations and depression. Sarcopenia appeared to drive these associations more than osteoporosis. Osteosarcopenia may be a risk factor for functional decline, hospitalization, and institutionalization, warranting further research. Osteosarcopenia is a disorder consisting of concurrent osteoporosis and sarcopenia. This cross-sectional study using nationally representative data from Finland in 2000 aimed to determine the prevalence of osteosarcopenia in Finland. In addition, associations of sociodemographic, lifestyle, anthropometric, physical and mental function indicators, chronic conditions and various biomarkers with osteosarcopenia were examined. The study included 2142 subjects aged 55 and over (mean age 68.0 years, SD 9.0). Probable sarcopenia was defined as grip strength < 27 kg for men and < 16 kg for women. Osteoporosis was defined as either ultrasound-based bone density measurement of T < -2.5, or self-reported, pre-existing diagnosis of osteoporosis. Participants were categorized into 4 groups: no sarcopenia and no osteoporosis, probable sarcopenia only, osteoporosis only, and osteosarcopenia. Information on sociodemographic, lifestyle, anthropometric, physical and mental function indicators, chronic conditions and various biomarkers were collected via structured interview, questionnaires, clinical examination, and blood and urine samples. The prevalence of probable sarcopenia, osteoporosis and osteosarcopenia was 13.8%, 11.1%, and 3.9%, respectively. Osteosarcopenia was associated with low BMI, slow gait speed, impaired mobility, impaired ability in the activities of daily living and depression. Of the two components, probable sarcopenia appeared to contribute to these associations more than osteoporosis. According to representative population-based study, about every fifth person with probable sarcopenia also has osteoporosis. Mobility and ADL limitations were more common among people with osteosarcopenia than those with osteoporosis or probable sarcopenia alone. Future studies are needed to examine osteosarcopenia as an independent risk factor for functional decline, hospitalization, and institutionalization.
Identifiants
pubmed: 39212839
doi: 10.1007/s11657-024-01439-7
pii: 10.1007/s11657-024-01439-7
pmc: PMC11364597
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
80Informations de copyright
© 2024. The Author(s).
Références
World Health Organ Tech Rep Ser. 1994;843:1-129
pubmed: 7941614
Osteoporos Int. 2021 Nov;32(11):2173-2183
pubmed: 33877382
Chron Respir Dis. 2017 Feb;14(1):85-99
pubmed: 27923981
J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1199-1204
pubmed: 29300839
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Scand J Med Sci Sports. 2016 Jan;26(1):93-100
pubmed: 25559167
Front Cell Dev Biol. 2020 Dec 10;8:585644
pubmed: 33363144
Eur Geriatr Med. 2018 Aug;9(4):419-434
pubmed: 34674498
Bone. 2003 May;32(5):571-8
pubmed: 12753874
Z Gerontol Geriatr. 2019 Nov;52(7):688-693
pubmed: 31049683
Age Ageing. 2016 Sep;45(5):602-8
pubmed: 27126327
Br J Hosp Med (Lond). 2018 May 2;79(5):253-258
pubmed: 29727228
Eur Geriatr Med. 2023 Apr;14(2):225-228
pubmed: 36869279
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36
pubmed: 27066316
Osteoporos Int. 2015 Dec;26(12):2793-802
pubmed: 26068298
J Clin Densitom. 2009 Oct-Dec;12(4):413-6
pubmed: 19733110
J Clin Epidemiol. 2006 Sep;59(9):994-1001
pubmed: 16895824
J Am Med Dir Assoc. 2016 Dec 1;17(12):1164.e7-1164.e15
pubmed: 27816484
PLoS One. 2020 Aug 7;15(8):e0237454
pubmed: 32764814
Biomolecules. 2020 Mar 10;10(3):
pubmed: 32164381
Diabetes Care. 2017 Dec;40(12):1710-1718
pubmed: 28986505
Public Health Nutr. 2010 Jun;13(6A):915-9
pubmed: 20513260
Scand J Public Health. 2006;34(4):378-86
pubmed: 16861188
Age Ageing. 2021 Nov 10;50(6):1906-1913
pubmed: 34537833
Bone. 2000 Nov;27(5):585-90
pubmed: 11062343
J Am Med Dir Assoc. 2015 Apr;16(4):290-5
pubmed: 25512216